Bare Metal Stents (BMS) (Coronary Stents) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
All the vital news, analysis, and commentary curated by our industry experts.
Bare metal stents (BMS) are uncoated stents that are permanently placed inside the artery. These stents are constructed from a range of metals, including nitinol, stainless steel, and cobalt-chromium. One unit refers to one bare-metal stent system. GlobalData’s Medical Devices sector report provides comprehensive information about the Bare Metal Stents (BMS) (Coronary Stents) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
What are the market dynamics in the bare metal stents pipeline products market?
As of November 2021, 4 pipeline products were in the clinical stage, and 1 product was in the pre-clinical and early development stages each. Less than 10 pipeline products were in the inactive stage. During the same period, based on pipeline products by stage of development, 4 products from AlviMedica Medical Technologies Inc were in the clinical process. Similarly, Nanova, Inc had 1 product in the pre-clinical stage. The US is the leading country in the market based on pipeline products by territory, followed by Japan, Europe and India.
Who are the key players in the bare metal stents pipeline products market?
Key players in the market are Advanced Bifurcation Systems Inc, AlviMedica Medical Technologies Inc, Atrium Medical Corp, MIV Therapeutics Inc, Nanova, Inc, Nexeon MedSystems Inc, Palmaz Scientific Inc (Inactive), Qvanteq AG, Rontis AG, Sree Chitra Tirunal Institute for Medical Sciences & Technology, and Viller Scientific LLC. AlviMedica Medical Technologies Inc is the leading company in the market based on the pipeline products in the clinical stage, while Viller Scientific LLC leads for products in the early development stage.
Advanced Bifurcation Systems Inc: Advanced Bifurcation Systems Inc is a medical device company focusing on technologies enabling and facilitating seamless stenting of all coronary bifurcation disease scenarios. The company manufactured the Stenting System – Bare Metal Stent (BMS) that is intended for the treatment of bifurcation lesions in coronary angioplasties. It is designed to widen and open the narrow coronary arteries to restore blood flow. It is based on Mother/Daughter (MD) Platform Technology. It consists of main and side branch stents that are independent, moveable, modular bifurcating stenting systems at the carina or fixed point of a bifurcation. It covers branch angles, sizes, and plaque locations. It features mechanically fail-safe, has no torqueing or micro alignment, no gaps and/or overlaps and reduces the risk of restenosis and thrombosis.
AlviMedica Medical Technologies Inc: AlviMedica Medical Technologies Inc (AlviMedica) is a medical device company that provides minimally invasive medical technologies. The company offers interventional cardiology and endovascular products. Its interventional cardiology products comprise tens, balloons, catheters, and guide wires. AlviMedica offers endovascular products such as renal region products, iliac region systems, femoro-popliteal region, and below-the-knee region products. The company develops minimally invasive medical technologies for medical professionals. It has its presence in Turkey, Italy, France, the Netherlands, Holland, India, China, Singapore, Brazil, Uruguay, Japan, the UK, the US, and others. AlviMedica is headquartered in Istanbul, Turkey.
Atrium Medical Corp: Atrium Medical Corp (Atrium Medical) a subsidiary of Getinge AB, is a medical device company that designs, develops, and manufactures diversified medical devices. The company provides ventricular assist device components, minimally invasive gastrointestinal, devices, arterio-venous access and peripheral by-pass devices, endovascular devices, coronary and peripheral angioplasty and stent deployment catheters, artificial heart components, soft tissue repair and support components, and balloon catheter components. Its services include research and development, manufacturing, customer service, clinical education, professional marketing and sales, and logistics services. Atrium Medical also provides clinical trials and management services. The company operates in Australia, Germany, the Netherlands, and the US. Atrium Medical is headquartered in Hudson, New Hampshire, the US.
The company manufactured the Next Generation Super Flexible Cobalt Chromium Coronary Stent that is intended to be used during percutaneous transluminal coronay angioplasty procedure to treat atherosclerosis. It is designed to widen and open the narrow coronary artery and restore the blood flow. It is stronger and more radiopaque than stainless steel, giving cobalt chromium stents thinner struts with good visibility.
MIV Therapeutics Inc: MIV Therapeutics Inc (MIVT) is a research and development company that develops biocompatible coatings for stents and other medical devices and advanced drug delivery systems. The company focuses on providing healing solutions for cardiovascular disease and other medical conditions. The company’s hydroxyapatite (“HAp”) based product the VESTAsync coronary drug-eluting stent system is in animal studies and human clinical trials. The company has collaborations with The University of British Columbia. It has developed coating technologies that utilize HAp for application on drug delivery systems and medical devices. The company also sells the GenX bare-metal coronary stent in Europe. The company is headquartered in Vancouver, British Columbia, Canada. The company manufactured Vestapor that is a next generation bare metal stent intended for the treatment of coronary artery disease. It is designed to widen and open the narrowed coronary arteries. It is based on the HAp Coating Technology.
Nexeon MedSystems Inc: Nexeon MedSystems Inc (Nexeon) is a bioelectronics company that develops and commercializes devices and therapies for the treatment of cardiovascular diseases. The company’s products include embolic protection systems, local drug, and biologic delivery systems, nanotechnology-based devices, and cell delivery and regenerative therapy devices. It develops anatomy-specific combination embolic protection and stent delivery systems for endovascular procedures. Nexeon also develops cell delivery and regenerative therapies for the delivery of stem cells and biologics to target end-organ sites in order to treat conditions such as acute myocardial infarction, chronic congestive heart failure, and chronic critical limb ischemia. The company offers its products across the US. Nexeon is headquartered in Dallas, Texas, the US.
Sree Chitra Tirunal Institute for Medical Sciences & Technology: Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST), formerly Sree Chitra Tirunal Medical Center, is a healthcare institute that offers medical device development, patient care, and health sciences studies. The institute’s activities include research and development in biomedical engineering and technology deliver high-quality patient care in selected specialties and subspecialties develop postgraduate training programs in advanced medical specialties, biomedical engineering, and technology, and participating in public health reforms through research, training, and interventions. It operates various departments including administrative and support services, anesthesiology, biochemistry, cardiology, clinical engineering, imaging sciences and intervention radiology, microbiology, neurology, neurosurgery, physical medicine and rehabilitation, transfusion medicine, and others. SCTIMST is headquartered in Thiruvananthapuram, Kerala, India.
The company manufactured Bare Metal Coronary Stent that is intended to be used during percutaneous transluminal coronary angioplasty procedures. It is designed to widen and open the narrow blood vessels to restore blood flow
To know more about key players, download a free report sample
Market report scope
|Key countries/regions||The US, Europe, India, and Japan|
|Key players||Advanced Bifurcation Systems Inc, AlviMedica Medical Technologies Inc, Atrium Medical Corp, MIV Therapeutics Inc, Nanova, Inc, Nexeon MedSystems Inc, Palmaz Scientific Inc (Inactive), Qvanteq AG, Rontis AG, Sree Chitra Tirunal Institute for Medical Sciences & Technology, and Viller Scientific LLC.|
- Extensive coverage of the bare metal stents under development.
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities.
- The report reviews the major players involved in the development of bare metal stents and lists all their pipeline projects.
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage.
- The report provides key clinical trial data of ongoing trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Identify and understand important and diverse types of bare metal stents under development.
- Develop market-entry and market expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- In-depth analysis of the product’s current stage of development, territory, and estimated launch date.
AlviMedica Medical Technologies Inc
Atrium Medical Corp
MIV Therapeutics Inc
Nexeon MedSystems Inc
Palmaz Scientific Inc (Inactive)
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Viller Scientific LLC
Table of Contents
|1 Table of Contents 3
|1.1 List of Tables 5
|1.2 List of Figures 6
2 Introduction 7
2.1 Bare Metal Stents (BMS) Overview 7
3 Products under Development 8
3.1 Bare Metal Stents (BMS) – Pipeline Products by Stage of Development 8
3.2 Bare Metal Stents (BMS) – Pipeline Products by Territory 9
3.3 Bare Metal Stents (BMS) – Pipeline Products by Regulatory Path 10
3.4 Bare Metal Stents (BMS) – Pipeline Products by Estimated Approval Date 11
4 Bare Metal Stents (BMS) – Pipeline Products under Development by Companies 12
4.1 Bare Metal Stents (BMS) Companies – Pipeline Products by Stage of Development 12
4.2 Bare Metal Stents (BMS) – Pipeline Products by Stage of Development 13
5 Bare Metal Stents (BMS) Companies and Product Overview 14
5.1 Advanced Bifurcation Systems Inc Company Overview 14
5.1.1 Advanced Bifurcation Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 AlviMedica Medical Technologies Inc Company Overview 15
5.2.1 AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Atrium Medical Corp Company Overview 18
5.3.1 Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 MIV Therapeutics Inc Company Overview 19
5.4.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 19
5.5 Nanova, Inc Company Overview 20
5.5.1 Nanova, Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.6 Nexeon MedSystems Inc Company Overview 21
5.6.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 21
5.7 Palmaz Scientific Inc (Inactive) Company Overview 22
5.7.1 Palmaz Scientific Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 22
5.8 Qvanteq AG Company Overview 23
5.8.1 Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview 23
5.9 Rontis AG Company Overview 24
5.9.1 Rontis AG Pipeline Products & Ongoing Clinical Trials Overview 24
5.10 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 25
5.10.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 25
5.11 Viller Scientific LLC Company Overview 26
5.11.1 Viller Scientific LLC Pipeline Products & Ongoing Clinical Trials Overview 26
6 Bare Metal Stents (BMS)- Recent Developments 27
6.1 Nov 18, 2021: MicroPort RehabTech TherMotion Cryo-Thermo compression device approved for marketing in China 27
6.2 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule 27
6.3 Nov 03, 2021: ICON reports third quarter 2021 financial results 27
6.4 Nov 02, 2021: Cordis Names Muscari President Of The Americas 29
6.5 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021 30
6.6 Oct 07, 2021: Construction begins on 280,000-square-meter MicroPort MegaFactory and global medical experience center 34
6.7 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting 35
6.8 Jul 27, 2021: Surmodics to Webcast Third Quarter Fiscal 2021 Earnings Conference Call on August 4 35
6.9 Jul 21, 2021: ICON Reports Second Quarter 2021 Results 35
6.10 Jul 21, 2021: ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting 38
6.11 Jun 30, 2021: B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer 39
6.12 May 24, 2021: Boston Scientific to Participate in Bernstein’s 37th Annual Strategic Decisions Conference 39
6.13 May 17, 2021: MicroPort Orthopedics holds joint workshop on joint surgery with China-Japan Friendship Hospital 39
6.14 May 05, 2021: ICON to Present at the BofA Securities 2021 Virtual Healthcare Conference and the UBS Virtual Global Healthcare Conference 40
6.15 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences 41
6.16 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021 41
6.17 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule 42
6.18 Feb 09, 2021: Surmodics Reports First Quarter Fiscal 2021 Results 42
6.19 Feb 01, 2021: Surmodics to Webcast First Quarter Fiscal 2021 Earnings Conference Call on February 9 43
6.20 Jan 07, 2021: MicroPort EP “Talents Program” holds first theoretical training to enhance arrhythmias treatment at primary hospitals 43
6.21 Jan 06, 2021: Abbott Hosts Conference Call for Fourth-Quarter Earnings 44
6.22 Dec 28, 2020: Cook Medical launches a new Customer Portal to enhance customer experience 44
7 Appendix 45
7.1 Methodology 45
7.2 About GlobalData 48
7.3 Contact Us 48
Frequently asked questions
Which are the key geographic regions in the bare metal stents pipeline products market?
The US is the leading country in the market based on pipeline products by territory, followed by Japan and Europe.
Who are the key players in the bare metal stents pipeline products market?
Key players in the market are Advanced Bifurcation Systems Inc, AlviMedica Medical Technologies Inc, Atrium Medical Corp, MIV Therapeutics Inc, Nanova, Inc, Nexeon MedSystems Inc, Palmaz Scientific Inc (Inactive), Qvanteq AG, Rontis AG, Sree Chitra Tirunal Institute for Medical Sciences & Technology, and Viller Scientific LLC.
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Business Intelligence & Marketing Manager, SAL Heavy Lift
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
Market Analyst & Management, Liebherr-Werk
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Head of Key Accounts, Saab AB
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Marketing Intelligence Manager, Portugal Foods
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Head of Customer Insight and Research, Standard Chartered
Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.
Head of Consumer Sensory Insights, Givaudan
“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”
Senior Account Manager, TSYS
GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.